Health
Lower Radiotherapy Dose Shows Promise for Treating HPV-Related Oropharyngeal Cancer – Cancer Network
Given the current study findings, investigators suggested intratherapy personalization of chemoradiotherapy may possibly facilitate marked de-escalation of radiotherapy…
De-escalation of radiotherapy to 30 Gy on the basis of intratreatment hypoxia imaging among patients with head and neck cancers related to human papillomavirus (HPV) infection is feasible, safe, and associated with minimal toxicity, according to a pilot study published in the Journal of the National Cancer Institute.1
Patients with HPV-related oropharyngeal cancers typically have good outcomes but experience clinically significant toxicities when treated with standard chemoradiotherapy at a dose…
-
General24 hours agoYounger generations are moving away from traditional media to fill their entertainment hours
-
Business23 hours agoThese ASX 200 shares could rise 50% to 60%
-
General23 hours agoAustralia’s Myanmar community mourns earthquake losses
-
General21 hours agoPeter Dutton partially walks back public service work-from-home vow